1. Home
  2. OVID vs MSAI Comparison

OVID vs MSAI Comparison

Compare OVID & MSAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OVID
  • MSAI
  • Stock Information
  • Founded
  • OVID 2014
  • MSAI 1995
  • Country
  • OVID United States
  • MSAI United States
  • Employees
  • OVID N/A
  • MSAI N/A
  • Industry
  • OVID Biotechnology: Pharmaceutical Preparations
  • MSAI
  • Sector
  • OVID Health Care
  • MSAI
  • Exchange
  • OVID Nasdaq
  • MSAI Nasdaq
  • Market Cap
  • OVID 47.1M
  • MSAI 42.1M
  • IPO Year
  • OVID 2017
  • MSAI N/A
  • Fundamental
  • Price
  • OVID $0.62
  • MSAI $1.34
  • Analyst Decision
  • OVID Strong Buy
  • MSAI Strong Buy
  • Analyst Count
  • OVID 6
  • MSAI 2
  • Target Price
  • OVID $4.03
  • MSAI $5.25
  • AVG Volume (30 Days)
  • OVID 467.5K
  • MSAI 256.3K
  • Earning Date
  • OVID 03-07-2025
  • MSAI 11-12-2024
  • Dividend Yield
  • OVID N/A
  • MSAI N/A
  • EPS Growth
  • OVID N/A
  • MSAI N/A
  • EPS
  • OVID N/A
  • MSAI N/A
  • Revenue
  • OVID $631,695.00
  • MSAI $7,616,000.00
  • Revenue This Year
  • OVID $71.38
  • MSAI $127.29
  • Revenue Next Year
  • OVID N/A
  • MSAI $229.75
  • P/E Ratio
  • OVID N/A
  • MSAI N/A
  • Revenue Growth
  • OVID 113.21
  • MSAI 30.50
  • 52 Week Low
  • OVID $0.56
  • MSAI $1.22
  • 52 Week High
  • OVID $3.79
  • MSAI $5.00
  • Technical
  • Relative Strength Index (RSI)
  • OVID 38.62
  • MSAI 42.88
  • Support Level
  • OVID $0.56
  • MSAI $1.22
  • Resistance Level
  • OVID $0.67
  • MSAI $1.95
  • Average True Range (ATR)
  • OVID 0.06
  • MSAI 0.13
  • MACD
  • OVID 0.00
  • MSAI 0.03
  • Stochastic Oscillator
  • OVID 35.94
  • MSAI 16.44

About OVID Ovid Therapeutics Inc.

Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential in-class mechanism of action.

About MSAI Infrared Cameras Holdings Inc.

MultiSensor AI Holdings Inc develops and sells a full-stack, AI-driven predictive maintenance solution. MultiSensor AI's SmartIR and associated software platforms, powered by AWS, leverage MSAI-built thermal imaging, visible imaging, acoustic imaging, vibration, and laser sensing devices for condition-based monitoring of critical mechanical and electrical assets and manufactured outputs. Its solutions are deployed by organizations to protect critical assets across a wide range of industries including distribution & logistics, manufacturing, utilities, and oil & gas. MSAI designs and manufactures digital thermal sensing solution platforms with edge and cloud-based software. The company generates the majority of its revenue from product sales.

Share on Social Networks: